Litcius/Paper detail

Effectiveness and Safety of Beta-Lactam Antibiotics with and without Therapeutic Drug Monitoring in Patients with Pseudomonas aeruginosa Pneumonia or Bloodstream Infection

Ashlan J. Kunz Coyne, Mohammad H. Al‐Shaer, Anthony M. Casapao, Veena Venugopalan, Carmen Isache, Jason Ferreira, Christopher Jankowski

2022Antimicrobial Agents and Chemotherapy12 citationsDOIOpen Access PDF

Abstract

0.001). BLA TDM had more 30-, 60- and 90-day infection-related readmissions ([aOR], 11.301, 95% CI (3.595 to 35.516); aOR 10.389, 95% CI [2.496 to 43.239], and aOR 24.970, 95% CI [6.703 to 93.028]) in IPTW analyses. For both unadjusted and IPTW-adjusted cohorts, there was no significant difference in hospital and ICU length of stay, adverse effects while on BLA, or microbiological eradication between BLA TDM and No-BLA TDM. In hospitalized adult patients with P. aeruginosa PNA or BSI, the use of TDM-guided BLA infusions decreased the odds of presumed treatment failure compared to patients receiving BLA infusions without TDM guidance. Future studies should evaluate BLA TDM impact on readmission.

Topics & Concepts

Pseudomonas aeruginosaMedicinePneumoniaAntibioticsBeta-Lactamase InhibitorsTherapeutic drug monitoringRetrospective cohort studyIntensive care medicineInternal medicineMicrobiologyPharmacokineticsBacteriaBiologyGeneticsAntibiotics Pharmacokinetics and EfficacyAntibiotic Use and ResistancePneumonia and Respiratory Infections